Dr. Salem A. BESHYAH
MBBCh DIC PhD FRCP
CONSULTANT PHYSICIAN
(DIABETES & ENDOCRINOLOGY)
 
beshyah@yahoo.com
 

CURRICULUM VITAE: EDUCATION & QUALIFICATIONS

EDUCATION:

1971- 1974 Suk El-Giuma Secondary School, Tripoli, Libya.

1974 - 1981 Faculty of Medicine, Al-Fateh University, Tripoli, Libya.

QUALIFICATIONS:

1981 MB, BCh. Al-Fateh University, Tripoli, Libya.

1987 MRCPI Royal College of Physicians of Ireland.

1987 MRCP(UK) Royal Colleges of Physicians (UK).

1994 DIC Imperial College London.

1994 PhD University of London.

2000 FRCP Royal College of Physicians of London

CURRICULUM VITAE:

SENIOR POSTS:

CURRENT

Current 17.9.2006 – Date

Senior Consultant Endocrinologist, Division of Endocrinology, Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE

 

I have been in post for nearly 1 year. I have joined 2 other senior endocrinologists. The services are focused at delivering high quality outpatients endocrine and diabetes services and high quality endocrine and diabetic consultations for inpatients under other specialities. I have 6 OPD clinics per week (4 endocrine clinics and 2 diabetic clinics) and 1:3 on call for the specialty.

 

During this period, I have contributed to the senior support of the departments (sharing the work equally with the two other senior consultants). My appointment helped reduced the waiting time to just around 2 weeks in addition to an increased to accommodate more urgent referrals.  In addition, I took on the role of coordinating the academic activities in the department. Examples include organizing the Departmental Weekly Multidisciplinary Meeting, World Diabetes Day Symposium 2006, Diabetes in the Real World 2007 for family physicians, Management of Chronic Medical Conditions during Ramadan.  In addition, I have served on the Scientific Committee of the SKMC Medicine Update 2007 (I indeed drafted the first version of the programme and proposed the idea of two land mark lectures). I have also served as the chair of the Scientific Committee for the Fifth Libyan Diabetes and Endocrinology Conference, secured it approval from the RCP London for 18 months. I have been also invited to serve on the Clinical Management Quality Committee and to undertake coordinating the Mortality and Morbidity Reporting and Meetings from October 2007 onwards.

           

 

            Referees:

            Consultant colleague:                        Dr. Ali Khalil, MD FRCPC

            Division Head:                                   Dr. Mahmoud Benbarka, MD FACE

            Chair, Department of Medicine:      Dr David Spence, MD FRCP FRCPath

 

1.5.1996-25.8.2006

Consultant Physician in General Medicine, Diabetes and Endocrinology and Unit Training Director for Medicine 

Princess Alexandra Hospital, Harlow, Essex.

 

·      I initially started this job as a locum for 4 months (May to August, 1996) during which I was appointed to the substantive post on the 26.July 1996.

·      This is a full-time NHS post.  The fixed sessions include 2 ward rounds and 4 OPD clinics together with acute medical on call rota of 1:6 for the first 4 years, now 1:12. One of the OPD clinics is a medical/endocrine and the other three are diabetic clinics (on three different sites to meet the geographical needs of the district).

·      The medical/diabetic firm consists of four junior doctors (a Diabetes Specialist Registrar on North Thames Rotation,  Staff Grade Doctor, a medical SHO on our 24  month rotation and a pre-registration House Physician), three Diabetes Specialist Nurses and a part time Diabetes Link Midwife,  and two Clinical Assisstant sessions in Diabetes Care. 

·      The diabetic care is delivered via the conventional diabetic clinics and by the three nurses following patients up in the community. A new Diabetes Education Centre is used for educational sessions, walk-in services and to see “out of clinic” consultations for urgent and high risk patients.  All OPD diabetic clinic sessions are supported by dietary advise and chiropody services.

·      There is a close cooperation with the local medical opthalmology unit (Miss Dierdre Flaye), and the vascular surgeon (Mr Refson). I have Combined Thyroid Clinic (1st Friday of the month) with the local thyroid surgeon (Miss Jenkins) and a Diabetic Ante-natal Clinic (Jointly with Mr Hartwell). I have established a close working relationship with Professor John P. Monson (Saint Bartholomew’s Hospital) for tertiary endocrine referrals and the Renal physicians in the surrounding hospitals for joint management of diabetic renal disease.

·      During this appointment I had been the Clinical Audit Lead and I ran an effective wel attended programme. For three years. (1.1.1997-31.12.1999).

·     I was the Unit Traing Director/Royal College Tutor (1.12003 - 8.9.2006). I run an active educational programme catering for the needs of the SHO’s preparing for the MRCP and other juniors.

 

I am very keen on continuing education. I regularly lecture and lead workshops for GP and Practice Nurses in the locality and the region in addition to my commitments to teaching of medical students and Junior Doctors in Hospital

 

                        Referees:        Dr. John Milne, Consultant Cardiologist

                                                Dr. Khalid Ahmed, Consultant Rheumatologist

                                                Dr. John Warren, Consultant Physician 

 

CURRICULUM VITAE: TRAINING POSTS:

1.3.81 - 28.2.82

Junior House Officer: Internship rotation in medicine and surgery, in the main teaching hospitals in Tripoli, Libya.

1.3.82 - 30.4.83

Senior House Officer: In general medicine, Tripoli Central Hospital, Tripoli Libya.

1.5.83 - 31.10.83

Senior House Officer: Intensive Care Unit, Tripoli Central Hospital, Tripoli, Libya.

1.11.83 - 30.9.85

S.H.O./Registrar: In general medicine (Endocrinology & Gastroenterology), Tripoli central hospital, tripoli, Libya.

1.11.85 - 26.2.86

Clinical Attachment:

General medicine, St Laurence's Hospital, Dublin, Ireland.

1.3.86 - 30.11.86

Senior House Officer: General medicine, Victoria Infirmary , Glasgow, Scotland.

1.12.86 - 20.3.87

Registrar: General medicine, Hairmyres Hospital, East Kilbride, Scotland

23.3.87 - 16.1.89

Registrar: General medicine (Diabetes and Endocrinology=19 months+ Gastroenterology= 3 months), Leicester General Hospital, Leicester., UK.

1.2.89-12.9.89

Registrar: General medicine (Diabetes and Endocrinology + Gastroenterology), Bedford General Hospital, Bedford. UK.

13.9.89 - 31.12.93

Clinical Research Fellow :(Clinical Endocrinology), Unit of Metabolic Medicine, St. Mary's Hospital Medical School, London, UK.

 

During this research fellowship working for Des Johnston, I have conducted clinical and metabolic studies on the consequences of conventionally-treated hypopituitarism in adults (body composition, bone mass and metabolism, quality of life and cardiovascular risk). I was also responsible on the planning and running of a trial of GH replacement therapy in hypopituitary adults to assess the effects on well-being, body composition, physical performance, bone mass and metabolism, lipid metabolism and carbohydrate tolerance. The work resulted in numerous presentations at National and International meetings and several publications in quality journals. In addition to the research work, I was doing regular endocrine, diabetes and lipid clinics at St. Mary's, St Charles’ and Northwick Park hospitals. Research fellows are also involved in the academic and clinical activities of the unit of metabolic medicine including teaching of medical students and supervision of the B.Sc. (Clinical Science) students during their research project module.

1.4.94- 30.4.96

Senior Registrar (locums): In general medicine,diabetes and endocrinology mainly at St. Mary's, Guy's, Wittington and Central Middlesex Hospitals, London, UK.

CURRICULUM VITAE: Publications and Presentations

A. Full Papers

1. Sherif IH, Vanderley C, Beshyah S & Bosairi S. Sella size and contents in Sheehan's syndrome. Clinical Endocrinology 1989; 30: 613-618.

2. Jones R, Beshyah SA, Curryer G & Burden AC. Modification to the "Leicester Scotchcast Boot". Practical Diabetes 1989; 6: 118 -119.

3. Beshyah SA and Sherif IH. Ramadan fasting and diabetes mellitus. Practical Diabetes Digest 1989;1: 31-32.

4. Beshyah SA, Anyaoku V, Niththyananthan R, Sharp P & Johnston D G. The effect of subcutaneous injection site on absorption of human growth hormone: Abdomen versus thigh. Clinical Endocrinology 1991; 35: 4-412

5. Shahi M, Beshyah SA, Hackett D, Sharp P, Johnston DG & Foale R. Myocardial dysfunction in treated hypopituitary adults: a possible explanation for increased vascular mortality. British Heart Journal 1992: 67: 92-96

6. Beshyah SA, Jowett NI, Burden AC. Metabolic control during Ramadan fasting. Practical Diabetes 1992; 9: 54-55

7. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN and Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188- 1192

8. Sharp P, Beshyah SA and Johnston DG. Growth hormone disorders and diabetes. In: Alberti KGGM & Johnston DG (eds.): Secondray Diabetes Bailliere's Clinical Endocrinology and Metabolism 1992; 6: 819-828

9. Johnston DG, Beshyah SA, Markussis V, Shahi M, Sharp P, Foale R and Skinner E. Metabolic changes and vascular risk factors in hypopituitarism. Hormone Research 1992; 38(S1): 68-72.

10. Beshyah SA, Markussis V, Harbourne T, Nicolaides AN and Johnston DG. Normal haemostatic mechanisms despite increased vascular mortality in hypopituitary adults. Hormone and Metabolic Research 1993; 25: 449-450.

11. Beshyah SA, Sharp P, Gelding SV, Halliday D & Johnston DG. Whole- body leucine turnover in adults on conventional treatment for hypopituitarism. Acta Endocrinologica 1993; 129: 158-164.

12. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A & Johnston DG. Effect of growth hormone replacement therapy on calcium and bone metabolism in hypopituitary adults. Clinical Endocrinology 1994; 40: 383-392.

13. Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R and Johnston DG. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. European Journal of Endocrinology 1994; 130: 451-458.

14. Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength before and during growth hormone treatment in hypopituitary adults: relationship to changes in lean body mass and IGF-I. Endocrinology and

Metabolism 1994; 1: 41-47.

15. Lynch S, Merson S, Beshyah SA, Sharp P, Skinner E, Priest RG & Johnston DG. Psychiatric morbidityin adults with hypopituitarism. Journal of The Royal Society of Medicine 1994; 87:445-447.

16. Beshyah SA, Anyaoku V, Newton P and Johnston DG. Metabolic abnormalities in growth hormone deficient adults: I. Serum insulin like growth factor-I. Endocrinology and Metabolism 1994; 1: 167-172.

17. Beshyah SA, Henderson A, Niththyananthan R, Sharp P, Richmond W and Johnston DG. Metabolic abnormalities in growth hormone deficient adults: II. Carbohydrate tolerance and lipid metabolism. Endocrinology and Metabolism 1994; 1: 173-180.

18. Al-Shoumer KAS, Beshyah SA and Johnston DG. Growth hormone and malignancy. Endocrine-Related Cancer 1994 1: 19-26.

19. Rutherford OM, Beshyah SA, Schott J, Watkins Y & Johnston DG. Contractile properties of the quadriceps muscle in growth hormone deficient hypopituitary adults. Clinical Science; 1995:88: 67-71.

20. Beshyah SA, Freemantle C, Shahi, M, Anyaoku, V, Merson S, Lynch S, Skinner E, Sharp P, Foale R and Johnston DG. Replacement treatment with biosynthetic human growth hormone in growth hormone deficient hypopituitary adults. Clinical Endocrinology 1995; 42: 73-84.

21. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. The effects of glucocorticoid replacement regimen on glucose tolerance and intermediary metabolism in hypopituitary adults. Clinical Endocrinology 1995; 42: 85-90.

22. Beshyah SA, Shahi M, Foale R and Johnston D G. Cardiovascular effects of prolonged growth hormone replacement in adults. Journal of Internal Medicine 1995; :237:35-42.

23. Beshyah SA, Freemantle C, Thomas E, Rutherford OM, Page B & Johnston DG. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clinical Endocrinology 1995; 42: 178-189.

24. Beshyah SA, Henderson A, Niththyananthan R, Skinner, E., Anyaoku, V., Richmond, W, Sharp P and Johnston DG. The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism 1995; 80: 356-

363.

25. Beshyah SA, Kyd P, Thomas E, Fairney A and Johnston DG. The effect of long-term growth hormone replacement therapy on bone metabolism and bone mineral density in hypopituitary adults. Clinical Endocrinology 1995; 42: 249-254.

26. Beshyah SA, Freemantle C, Thomas E, Page B, Murphy M & Johnston DG. Comparison of body composition measurements derived from total body potassium, bio-impedance analysis and dual energy X-ray absorptiometry in hypopituitary adults before and during growth hormone replacement. American Journal of Clinical Nutrition 1995; 61: 1186-1194.

27. Beshyah SA, Rutherford OM, Thomas E, Murphy M & Johnston DG. Assessment of regional body composition by dual energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. Endocrinology and Metabolism 1995; 2: 147-155.

28. Beshyah SA, Henderson A, Baynes C, Copping D, Richmond W and Johnston DG. Post-heparin plasma lipase activity in hypopituitary adults. Hormone Research 1995, 44:69-74.

29. Beshyah SA, Gelding SV, Andres C, Johnston DG and Gray IP. Beta cell function in hypopituitary adults before and during growth hormone treatment. Clinical Science 1995; 89: 321-328.

30. Beshyah SA, Shahi M, Mayet J, Foale R and Johnston DG. Growth hormone and the cardiovascular system. In: M. Ranke and J.S. Christiansen (eds). The Complexity of Endocrine Systems. J &J-Verlag , Mannaheim, 1996: pp 131-155.

31. Al-Shoumer KAS, Page B, Thomas E, Beshyah SA & Johnston DG. Effects of four years’ treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults. European Journal of Endocrinology 1996; 135: 559-567

32. Markussis V, Beshyah SA, Fisher C, Parker K, Nicolaides AN & Johnston DG. Abnormal carotid wall arterial wall dynamics in symptom-free hypopituitary adults. European Journal of Endocrinology 1997; 136: 157-164.

33. Johnston DG, Al-Soumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku. Interactions of cortisol and growth hormone replacement: Intermediary metabolism. In: SWJ Lamberts (Ed.) The Diagnosis and Treatment of Pituitary Insufficiency. BioScientifica Ltd. Bristol. 1997: pp 63-77.

34. Sherif IH & Beshyah SA. Diabetes and Ramadan. In: G.V.Gill, J-C Mbanya & G. Alberti (Eds.) Diabetes in Africa. FSG Communications Ltd. Cambridge. 1997, pp 269-273.

35. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku. Growth hormone replacement in young adults: if and when to continue. In: R Stanhope (ed) Adolescent Endocrinology BioScientifica Ltd. Bristol. 1998; pp17-23.

36. Al-Shoumer KAS, Gray R, Anyaoku V, Huges C, Beshyah S, Richmond W & Johnston DG. Effects of four years’ treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical Endocrinology 1998; 48: 795-802

37. Chrisoulidou A, Kousta E, Beshyah SA, Robinson S and DG Johnston. How much and by what mechanisms does growth hormone replacement improve the quality of life in GH-deficient adults ? In: S M Shalet (ed.): Growth hormone in Adults. Bailliere's Clinical Endocrinology and Metabolism 1998; 12:2: 261-279.

38. Beshyah SA and Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clinical Endocrinology. 1999; 50:1-15

39. Beshyah SA. Is cardiovascular mortality increased in hypopituitary adults ?. In: J.P.Monson. Challenges in Growth Hormone Therapy. Blackwell Science. (Oxford) 1999; pp93-105.

40. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S. Long tern effects of growth hormone therapy on intermediary metabolism and insulin sensitivity Journal of Endocrine Investigations 1999; 22(5 Suppl):37-40

41. Beshyah, S. Islamic views on medical ethics. [Translation to Arabic]. Bulletin of the Islamic Call Society (Tripoli, Libya). 1998; 15:827-832. نظرة إسلامية في مبادئ الأخلاق الطبية (مقالة مترجمة من الإنجليزية إلى العربية) المؤلف ي. الحق ترجمة سالم العريفي بشيه. مجلة كلية الدعوة الإسلامية العدد الخامس عشر الصفحات 827 إلى 832 سنة النشر 1998

42. Chrisoulidou A., Beshyah SA, Rutherford O., Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R and Johnston DG. Effects of seven years growth hormone (GH) replacement therapy in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 2000 85: 3762 - 3769.

43. Bosseri S & Beshyah SA. Characteristics of diabetic patients with end-stage renal failure on haemodialysis in Tripoli, Libya. Diabetes International 2001; 11: 19 - 21.

44. Beshyah SA, Lakhdar A and Gill GV. Acute diabetic emergencie in the Arab World. In: A A Lakhdar & GV Gill (Editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005, pp: 199-210.

45. Beshyah SA and Sherif I. Diabetes during Ramadan and Haj. In: A A Lakhdar & GV Gill (Editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005, pp: 225- 240.

46. Beshyah SA and Blouza-Chabchoub S. Diabetes and Pregnancy. In: A A Lakhdar & GV Gill (Editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005, pp 249-267.

B. Abstracts of Presentations:

1. Beshyah SA & Burden AC. Haemoglobin, haematocrit and foot ulceration. Diabetic Medicine 1988; 5 (Suppl): 30

2. Burden A C, Jones R, Beshyah S A & Curryer G. Modification of the "Scotchcast Boot". Diabetic Medicine 1988; 5 (suppl): 30

3. Beshyah S A, Jowett N I & Burden A C. Effects of Ramadan fasting on metabolic control in diabetes. Diabetic Medicine 1988; 5 (suppl.): 32-33.

4. Jowett N I, Ray-Chaudri K, Beshyah S & Burden A C. Standard diabetic care and serum cholesterol. Diabetic Medicine 1989; 6 (suppl 2): 27A

5. Lynch S, Beshyah SA, Merson S, Sharp P, Priest RG & Johnston DG. Psychological features of growth hormone deficiency in adults. Journal of Endocrinology 1990; 127 (Suppl): 60

6. Copping D, Beshyah SA, Baynes C, Henderson A, Richmond W, Sharp P & Johnston DG. Plasma lipids, body fat distribution and plasma lipase activity in growth hormone deficient adults. Journal of Endocrinology 1990; 127 (Suppl): 61

7. Beshyah SA, Sharp PS, Anyaoku V, Fishman D & Johnston DG. Absorption of subcutaneously injected human growth hormone. Journal of Endocrinology 1990; 127 (Suppl): 59

8. Beshyah SA , Freemantle C, Parnell J, Johnston DG & Sharp P. Body composition in hypopituitarism: bioelectrical impedance versus total body potassium. Journal of Endocrinology 1991; 129 (Suppl): 232

9. Shahi M, Beshyah S, Hackett D, Sharp P, Foale R & Johnston D G. The effect of growth hormone deficiency on cardiac structure and function in hypopituitarism. Journal of Endocrinology 1991; 129 (Suppl): 179

10. Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. Cardiac structure and function in growth hormone deficiency. British Heart Journal 1991; 66(1): 58

11. Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. The effects of growth hormone deficiency on cardiac structure and function. European Heart Journal 1991; 12 (8-Abstracts Supplement): P389

12. Beshyah SA, Thomas E, Sharp P and Johnston DG. Bone mineral status in hypopituitary adults. Journal of Endocrinology 1991; 131 (Suppl): 95

13. Markussis V, Beshyah S A, Fisher C, Renton S, Nicolaides AN and Johnston D G.Increased carotid intima-media thickness in hypopituitary adults. Journal of Endocrinology 1991; 131 (Suppl): 96

14. Newton PJ, Beshyah SA, Anyaoku V, Sharp P and Johnston DG. Time course of metabolic response to subcutaneously injected human growth hormone. Journal of Endocrinology 1991; 131 (Suppl): 45

15. Beshyah SA, Anyaoku V, Skinner E, Niththyananthan R, Sharp P and Johnston DG. Increased diabetes and glucose intolerance in adults treated for hypopituitarism. Journal of Endocrinology 1992; 132 (Suppl): 240

16. Markussis V, Beshyah SA, Harbourne T, O'Brien D, Chrysanthou B, Nicolaides AN and Johnston DG. Increased vascular mortality in hypopituitary adults is not contributed to by abnormal clotting mechanisms. Journal of Endocrinology 1992; 132 (Suppl): 241

17. Beshyah SA , Kyd PA, Sharp P, Johnston DG & Fairney A. Biochemical markers of bone formation in hypopituitary adults. Bone and Mineral 1992; (Suppl 1) 222

18. Beshyah SA, Gelding SV, Robinson S, Murphy C, Sharp P, Halliday D & Johnston DG. Leucine turnover in hypopituitary adults. Clinical Science 1992; 83: 4P-5P.

19. Shahi M, Beshyah S, Sharp P, Johnston D G & Foale R. Beneficial effects of growth hormone replacement therapy on myocardial function. British Heart Journal 1992; 68(1): 129

20. Beshyah S A, Markussis V, Fisher C, Nicolaides AN and Johnston D G. Vascular disease in hypopituitary adults . Cardiovascular Disease Prevention: UK 1992 held on 28-31 July 1992, London. Conference Programme and Abstracts Book (Poster number 23, page 45).

21. Beshyah S A, Henderson A, Niththyanathan R, Skinner E, Baynes C, Richmond W and Johnston DG. The atherogenic risk factors in hypopituitary adults. Cardiovascular Disease Prevention: UK 1992 held on 28-31 July 1992, London . Conference Programme and Abstracts Book ( Poster 24, Page 45).

22. Beshyah S A, Henderson A, Anyaoku V, Baynes C, Richmond W, Sharp P and Johnston DG. Metabolic risk factors for vascular disease adult hypopituitarism. Ninth International Congress of Endocrinology, 1992: Abstract P.11.03.053), Nice, France.

23. Markussis V, Beshyah S A, Fisher C, Nicolaides AN and Johnston D G. Abnormal carotid compliance and distensibility in hypopituitarism. Ninth International Congress of Endocrinology, 1992: Abstract N= P.08.01.045), Nice, France.

24. Beshyah SA, Sharp P, Anyaoku V, Henderson A, Niththyananthan R, Skinner E, Freemantle C, Parnell CJ, Richmond W & Johnston DG. Effects of growth hormone replacement on body composition, lipid metabolism and carbohydrate tolerance in 40 hypopituitary adults. Journal of Endocrinology 1992; 135 (Suppl): P114

25. Beshyah SA, Sharp P, Kyd P, Thomas E, Fairney A & Johnston DG. The effect of biosynthetic human growth hormone (replacement) therapy on calcium and bone metabolism in hypopituitary adults. Journal of Endocrinology 1992; 135 (Suppl): P119

26. Beshyah SA, Sharp P, Halliday D & Johnston DG. The effects of growth hormone therapy on leucine metabolism in hypopituitary adults. Clinical Science 1993; 84: 43p

27. Beshyah SA, Anyaoku V, Newton P, Sharp P & Johnston DG. Clinical and anthropometric correlations of serum insulin-like growth factor 1 in growth hormone deficient adults. Journal of Endocrinology 1993; 137 (Suppl): P138

28. Beshyah SA, Gray IP, Niththyananthan R, Andres C & Johnston DG. The effect of growth hormone therapy on fasting insulin and proinsulin levels in hypopituitary adults. Journal of Endocrinology 1993; 137 (Suppl): P139

29. Beshyah SA, Shahi M, Anyaoku V, Skinner E, Sharp P, Foale R & Johnston DG. Clinical and physiological effects of biosynthetic human growth hormone replacement therapy in hypopituitary adults. Clinical Science 1993;

85 (Suppl.29):1P.

30. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. Glucocorticoid replacement regimen and glucose tolerance in hypopituitary adults. Journal of Endocrinology 1993; 139 (Suppl.): P126

31. Beshyah SA, Rutherford OM, Thomas E, Murphy M & Johnston D.G. Regional body fat distribution in hypopituitary adults before and after growth hormone treatment: A study by dual energy X-ray absorptiometry. Journal of Endocrinology 1993; 139(Suppl.): P127

32. Beshyah SA, Henderson A, Niththyananthan R, Anyaoku V & Johnston DG. Does glucocorticoid replacement therapy contribute to the increased vascular risk in growth hormone deficient hypopituitary adults ? Journal of Endocrinology 1993; 139 (Suppl.):P128

33. Rutherford OM, Beshyah SA, Watkins Y, Schott J & Johnston DG. Contractile properties of the quadriceps muscle in growth hormone deficient hypopituitary adults. Journal of Endocrinology 1993; 139 (Suppl.):P129

34. Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength in adult growth hormone deficiency before and during growth hormone treatment. Journal of Physiology 1993:473: 213P.

35. Beshyah SA, Freemantle C, Page B, Thomas E, Murphy M & Johnston DG. Changes in body composition during growth hormone therapy in adults: Comparison of total body potassium, bio-impedance and dual energy X-ray absorptiometry. Clinical Science 1994; 83 (suppl 30): P22

36. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. Day to day variation in glucose tolerance and intermediary metabolites caused by glucocorticoid replacement therapy in hypopituitary adults. Clinical Science 1994; 83 (Suppl 30):P22

37.Beshyah SA, Freemantle C, Shahi M, Foale R and Johnston D.G. Effects of long term growth hormone replacement in hypopituitary adults on body composition, exercise tolerance and muscle strength. Journal of Endocrinology 1994; 140 (Suppl.) :P166.

38. Beshyah SA, Henderson, A, Richmond, W and Johnston, D.G. The effect of long term growth hormone replacement in hypopituitary adults on plasma lipids, lipoproteins and apoproteins. Journal of Endocrinology 1994; 140 (Suppl.) :P165.

39. Al-Shoumer KAS, Andres C, Beshyah SA, Gray, IP and Johnston DG. Day to day variation in pancreatic beta cell products caused by glucocorticoid replacement therapy in hypopituitary adults. Journal of Endocrinology 1994; 140 (Suppl.) :P164.

40. Beshyah SA, Niththyananthan R, Skinner E, Sharp P and Johnston DG. The effect of long term growth hormone replacement on carbohydrate tolerance in hypopituitary adults. Endocrinology and Metabolism 1994;1 (Suppl. B): 32

41. Beshyah SA, Skinner E, Aghil FM and Johnston DG. Resting energy expenditure in growth hormone deficient adults. Journal of Endocrinology 1994; 143 (Suppl.): P75.

42. Beshyah SA, Kyd P, Fairney A and Johnston DG. The effects of long term growth hormone replacement therapy on calcium and bone metabolism in hypopituitary adults. Bone 1994; 15: 729-730.

43. Beshyah SA, Skinner E, Aghil FM and Johnston DG. The effect of growth hormone replacement on resting energy expenditure in growth hormone deficient adults. Journal of Endocrinology 1995;144: P293.

44. Beshyah SA, Shahi M, Mayet J, Skinner E, Foale R and Johnston DG. Heart size and function in hypopituitary adults: Comparison with normal controls and clinical and metabolic correlations. Journal of Endocrinology 1995; 147: OC46.

45. Al-Shoumer KAS, Hughes C, Richmond W, Beshyah SA and Johnston DG. Beneficial changes in plasma lipids, lipoproteins in hypopituitary adults after 4 years of growth hormone replacement therapy. Journal of Endocrinology 1995; 147: OC47.

46. Chrisouidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S and Johnston DG. Effects of GH treatment for 7 years versus no treatment on anthropometry and vascular risk factors in adult hypopituitarism. Journal of Endocrinology 1998; 150(Suppl.): P151

47. Chrisoulidou A, Kyd P, Beshyah SA, Rutherford O, Fairney A and Johnston DG. Effects of 7 years of growth hormone (GH) treatment on bone metabolism in adult hypopituitarism. Endocrinology. Proceedings of the 81st Meeting of the Endocrine Society, San Diego, 12-15 June 1999. P2-540 p394,

48. Chrisoulidou A, Ariff B, Mayet J, Beshyah SA, Shahi M, Foale R and Johnston DG. Effects of 7 years of growth hormone (GH) treatment on heart function and structure in adult hypopituitarism. Proceedings of the 81st Meeting of the Endocrine Society, San Diego, 12-15 June 1999: P2-528 pp 392.

49. Bosseri, S, Beshyah SA, Ismail MMA, Lazreg I, Shafeh T & Sherif IH. Clinical and biochemical characteristics of 270 Sheehan’s syndrome patients. Journal of Endocrinology. 2000.:

50. Ismail, MMA; Alaswad, M; Ejamail, A; Abdelaziz, H; Shawesh, K, Dorar, N; Beshyah S & Sherif, I. Metabolic control of type 2 diabetes using Repaglinide during the fasting month of Ramadan; IDF Programme Book; Abstract P332, November 2000.

51. Khawaja T, Alaswad M, Kekkli M, Beshyah SA & Sherif IH. Reduced bone mass in Sheehan’s syndrome. Endocrine Abstracts 2001; 1: P11

52. Abouglila K, Magbari M, Sayer JW & Beshyah, SA. Management of hyperglycaemia during acute myocardial infarction: an audit of DIGAMI-based practice Diabetic Medicine 2001;

53. Beshyah SA, Bay NA and Sherif IH. Awareness of libyan women of the menopause. Third Pan Arab Congress

on Endocrinology and Diabetes. Damacus October 25th-28th 2001. Proceedings Book.

54. Beshyah SA, Bisheya AF, El-Mijbri S. and Sherif IH. ole of community pharmacists in diabetes care.Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001.

55. Beshyah SA and Sherif IH. A “Short Diabetes Knowledge Test” in Arabic. Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001.

56. Beshyah SA, Aylwin S, Abouglila K & Monson JP. 'Brittle Addison's disease' but not 'Brittle diabetes' in a young woman with Addison's disease and type 1 diabetes mellitus. I. Endocrine Abstracts 2002, 3: P19

57. Khoo B, Field B, Rosenfelder B, Lowe DG, Beshyah SA& JP Monson Cushing's syndrome due to apparently autonomous adrenal hyperplasia in a patient with multiple endocrine neoplasia type I. Endocrine Abstracts 2002, 3: P122

58. Beshyah SA, Bay NA & Sherif IH. Awareness of Libyan women of the menopause and their attitudes to hormone replacement therapy. Endocrine Abstracts 2002, 3: P214

59. Ravikumar C, Mukhtar SF & Beshyah SA. Transient thyrotoxicosis following total laryngectomy Endocrine Abstracts 2002; 4:P8

60. Mukhtar SF and Beshyah SA. Unusualy long 'honeymoon' in a 45 year old man with type 2 diabetes mellitus Diabetic Medcine 2004; 21(suppl.):P214.

61. Beshyah SA, Al-Fallouji H & Neave F. Complete right vocal cord paralysis: a very rare complication of radioiodine therapy for hyperthyroidism. Endocrine Abstracts 2004, 7: P301

62. Beshyah SA. Epidemiology, clinical management and outcome of diabetic pregnancies in the Arab world: An overview. Programme Book. 1st International Meeting of the Gulf Group for the Study of Diabetes. February 12-15, 2005. Dubai, UAE (invited).

63. Beshyah SA. Evaluation and management of clinically-inapperent adrenal masses (incidentaloma) Programme Book. 6th Pan Arab Congress of Endocrinology and Diabetes .March 2-4, 2005 Alexandria, Egypt (invited)

64. Beshyah SA. Optimal use of the old and newer oral antidiabetic drugs.  Abstract Book of The Fourth Libyan Diabetes and Endocrinology Conference 2006:WS1.2 (invited)

65.Koduah D, Stoner E, Phillips R and Beshyah SA. Lesson of the week: delayed diagnosis of secondary hypoadrenalism due to isolated ACTH deficiency in an adult because of lack of hyperpigmentation and electrolyte disturbances Abstract Book of The Fourth Libyan Diabetes and Endocrinology Conference 2006:P04

 

66. Ala S. SAGAR, Ibrahim H. SHERIF and Salem  A. BESHYAH .  The practical diabetes knowledge of the final year medical students in Tripoli, Libya.  Abstract Book of The Fourth Libyan Diabetes and Endocrinology Conference 2006:P09

 

67. Beshyah SA and Sherif IH. Medical complications of obesity in adults. Libyan Journal of Medicine. 2007; 2 (supplement 2): S2.1

 

68. Beshyah SA and Benbarka MM. Hospitalization pattern of people with diabetes . Libyan Journal of Medicine. 2007; 2 (supplement 2): P8.

 

C. Letters, Proceedings, Book reviews:

1. Beshyah SA. Thyroid emergencies (letter). Hospital Update 1987;13: 585

2. Beshyah SA. Coding human insulin (letter). Practical Diabetes 1987; 4: 245.

3. Beshyah SA, Thomas E, Skinner E, Sharp P & Johnston DG. Total body and spine bone mineral density in women with hypopituitarism (Proceedings). In: Ring EFJ, ed. Current Research in Osteoporosis and Bone Mineral Measurement II:1992. London: The British Institute of Radiology,1992: pp 17-18

4. Beshyah SA, Thomas E, Freemantle C, Parnell CJ and Johnston DG. The place of dual energy X-ray absorptiometry in measurement of lean body mass and percent body fat in hypopituitary adults (Proceedings). In: Ring EFJ, (ed). Current Research in Osteoporosis and Bone Mineral Measurement II:1992. London: The British Institute of Radiology, 1992: pp 62-63

5. Sharp P, Beshyah SA and Johnston DG. Cardiovascular risk factors in growth hormone deficiency: effects of growth hormone replacement Endocrinology and Metabolism 1995; 2 (Suppl A): 13-14.

6. Lynch S, Beshyah S & Merson S. Psychiatric aspects of hypopituitarism (letter). Journal of The Royal Society of Medicine 1995; 88:603-604

7. Beshyah SA, Schiff R & Al-Jehani FS. National crash call number is needed (letter). Br. Med. J. 1996; 313; 429.

8. Al-Shoumer KAS, Kousta E, Beshyah S and Johnston DG. GH deficiency - Does it cause atherosclerosis ? The 3rd Internationational hGH symposium on GH deficiency in Adults. Vienna , 6 September 1996.

9. Beshyah SA. Taking growth hormone away from paediatrics (Book review). Lancet, 1997; 349:366-367.

 

10. Salhin AA, Hajjaji IM, Deeb AA and Beshyah SA. Meeting Report: The Fifth Libyan Diabetes and Endocrinology Conference, 1-3 May 2007, Teachers’ Union Hall, Tripoli, Libya. Libyan Journal of Medicine. 2007, 2: AOP.

 

11. Al Hajjery, OM, Majdi G and Beshyah SA. Meeting Report: Sheikh Khalifa Medical City Medicine Update 2007, Hilton Hotel, Abu Dhabi, UAE. 24-26th April 2006. Libyan Journal of Medicine. 2007, 2: AOP.

 

D. Patients’ Educational Leaflets/Booklets:

1. Beshyah SA. The Basic Information on Diabetes: A simplified guide for Arab diabetic patients in Britain (Patients Information Booklet; Arabic). Arab Health Care Foundation, London. 1996

المعلومات الأساسية عن السكري

2. Issam M Hajjaji & Salem A Beshyah. Guide to Diabetes in Libya (in Arabic): 2002

دليل مرض السكرفي ليبيا
 

CURRICULUM VITAE: POSTGRADUATE COURSES:

1. "Emergencies in Medicine" Southern General Hospital, Glasgow. 30 Sep. - 2 Oct. 1986,

2. "Diabetes 1988" An advanced postgraduate course, University of Sheffield. 5-8 January 1988.

3. BPMF's "Advanced Course in Endocrinology", London. 9-20 May 1988.

4. "25th Advanced Medicine Conference", Royal College of Physicians, 13-16/2/89.

5. "7th Advanced Medicine Course", Royal South Hants Hospital, Southampton. 22-26 May 1989.

6. "Patient Radiation Protection Course", Royal Free Hospital, London December 1989.

7. " Postgraduate Training Course in Endocrinology", St. Bartholomew’s Hospital, January 1993

8. "Acromegaly: 100 years of treatment", Royal Society of Medicine, London, September 1993.

9. "Postgraduate Training Course in Endocrinology", The Middlessex Hospital, January 1996

10. “Adolescent Endocrinology” Cambridge 15-16 October 1996

11. “ The 4th Oxford Symposium on Controversies in Diabetes” Oxford 3-4 July 1997

12. Diagnosis and Treatment of GHD in Children and Adolescents. Ten Years after the availability of recombinant

HGH: Towards a Consensus. Pisa, Italy 27-28 March 1998. (Invited Participant)

13. Erectile dysfunction: Pathophysiology and management. Study day. Cambridge 4th June 1998

14. The Advanced UK Diabetes Course, 24-26th June 1998, University of Liverpool, UK

15. Cardiovascular Disease Prevention IV. London 29th September to 3rd October 1998.

16. Medic Africa 24, Tripoli. Libya

17. Advanced Endocrine Course, Reading 2004

18. Medic Afric 28 2005

19. Advanced Medcine Course, Royal College of Physician of London, UK. March 2006

 

20. SKMC Medicine update 24-26 April 2007, Abu Dhabi, UAE.

 

 

OTHER ACADEMIC ACTIVITIES:

1. Membership of learned societies:

2. I have acted as a referee for the following journals:

3. Chair of the Programme Organizing Committe for The Fourth Libyan Diabetes and Endocrinology Conference, 29th April 29- 1st May 2006, Tripoli, Libya and the Fifth Libyan Diabetes and Endocrinology Conference 1-3 May 2007, tripoli Libya.

4. Web master for The Libyan Society for Diabetes and Endocrinology:

HOBBIES AND INTERESTS:

Music, history and photography.

MY LIST OF LINKS